Bleomycin
Bleomycin
Cytoprotective Agent
NADAC/unit
$25.2260
No Shortage
4 Manufacturers
8 ANDAs
vs. brand Bleomycin: Generic saves up to -152% per unit
Active Shortages
2025-06-13 Discontinuation of the manufacture of the drug, Hospira, Inc., a Pfizer Company
2025-06-13 Discontinuation of the manufacture of the drug, Hospira, Inc., a Pfizer Company
Market Intelligence
2024-01-31 Class I Recall: PFIZER
Generic Manufacturers
FRESENIUS KABI USA LLCHIKMA PHARMACEUTICALS USA INCHOSPIRA INCMEITHEAL PHARMACEUTICALS INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.